ASH Clinical News October 2017 | Page 47

CLINICAL NEWS Can a Post-AHCT, High-Intensity Exercise Program Improve Quality of Life in Patients With Myeloma? Patients with myeloma who undergo autologous hematopoietic cell transplantation (AHCT) may experience a decline in health-related quality of life (HRQoL). Although exercise has been shown to improve physical fitness and cancer-related fatigue for other conditions, researchers found that a prescribed high-intensity exercise program provided no substantial benefits over usual care, according to a study published in PLoS One. In the single-blind, multicenter, prospective, randomized, controlled EXIST (EXercise Intervention after Stem cell Transplantation) study, Saskia Persoon, PhD, from the Department of Rehabilitation at the Academic Medical Center at the University of Amsterdam in the Netherlands, and co-authors compared physical fitness – and HRQoL– outcomes between patients assigned to usual care and those assigned to an 18-week high- intensity resistance exercise and interval training program. “[We observed] no significant favorable